| Tap a line for its trend | Currentlast close | FY26Mar 2026 |
|---|
| 178 | 178 | |
| 1,680 | 1,680 | |
| 125 | 125 | |
| 7.4% | 7.4% | |
| 117 | 117 | |
| 84.0 | 84.0 | |
| 5.0% | 5.0% | |
| −8.3 | −8.3 | |
From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY26 31/03/2026 | Current last close | |
|---|---|---|---|
| - Cash, Equiv & ST Investments | 177.6 | 177.6 | |
| Revenue | 1,680.5 | 1,680.5 | |
| EBITDA | 124.6 | 124.6 | |
| Margin % | 7.42 | 7.42 | |
| EBIT | 116.7 | 116.7 | |
| Net Income | 84.0 | 84.0 | |
| Margin % | 5.00 | 5.00 | |
| Capital Expenditures | -8.3 | -8.3 | |
Figures from the company's filings with NSE
In FY26 its consolidated net profit was ₹84 crore on revenue of ₹1,680 crore.
KSE's net worth — shareholders' equity in its consolidated balance sheet — was ₹350 crore on 31 March 2026.
In FY26 (April 2025–March 2026), KSE's consolidated net profit was ₹84 crore, on revenue from operations of ₹1,680 crore.
On FY26 consolidated figures, against Narmada Agrobase and Mukka Proteins: KSE's operating margin of 6.9% is the highest of the three (Narmada Agrobase 6.1%, Mukka Proteins 6.8%; peer average 6.4%).
In 2026, KSE has declared two dividends totalling ₹12.50 a share: ₹5 (interim) with record date 21 February 2026 and ex-date 20 February 2026 and ₹7.50 with record date 21 August 2026.
In FY26, KSE earned net profit of ₹84 crore on revenue of ₹1,680 crore, against ₹3.9 crore on ₹78.4 crore for Narmada Agrobase. KSE's operating margin was 6.9% (Narmada Agrobase 6.1%).
From KSE's own consolidated results, balance sheets and shareholding patterns filed with NSE. Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.